Back to top
more

Aveanna Healthcare (AVAH)

(Delayed Data from NSDQ)

$2.27 USD

2.27
39,534

-0.05 (-2.16%)

Updated Apr 23, 2024 04:00 PM ET

After-Market: $2.26 -0.01 (-0.44%) 5:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (156 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Aveanna (AVAH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

While the top- and bottom-line numbers for Aveanna (AVAH) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Aveanna Healthcare (AVAH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aveanna (AVAH) delivered earnings and revenue surprises of 50% and 3.12%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Has Aveanna Healthcare (AVAH) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Aveanna Healthcare (AVAH) and Bausch Health (BHC) have performed compared to their sector so far this year.

Aveanna (AVAH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

RadNet (RDNT) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of 133.33% and 2.74%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Aveanna (AVAH) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

by Zacks Equity Research

Get a deeper insight into the potential performance of Aveanna (AVAH) for the quarter ended September 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Waters (WAT) Q3 Earnings Beat Estimates, Revenues Rise Y/Y

by Zacks Equity Research

Waters' (WAT) Q3 results benefit from a strong Pharmaceutical market, as well as a strong contribution from the Wyatt acquisition.

The Pennant Group, Inc. (PNTG) Soars 5.6%: Is Further Upside Left in the Stock?

by Zacks Equity Research

The Pennant Group, Inc. (PNTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Aveanna (AVAH) Reports Q2 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aveanna Healthcare (AVAH) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aveanna (AVAH) delivered earnings and revenue surprises of 50% and 4.14%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

RadNet (RDNT) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of 242.86% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health Incorporated (ELAN) Stock Jumps 11.7%: Will It Continue to Soar?

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aveanna (AVAH) delivered earnings and revenue surprises of 16.67% and 3.53%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LifeStance Health Group (LFST) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

LifeStance Health (LFST) delivered earnings and revenue surprises of 18.18% and 2.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

RadNet (RDNT) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of -14.29% and 5.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

The Joint Corp. (JYNT) delivered earnings and revenue surprises of 850% and 3.60%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Aveanna Healthcare (AVAH) Q1 Earnings Expected to Decline

by Zacks Equity Research

Aveanna (AVAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Option Care (OPCH) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Option Care (OPCH) delivered earnings and revenue surprises of 23.53% and 1.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Aveanna Healthcare (AVAH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aveanna (AVAH) delivered earnings and revenue surprises of -50% and 0.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

LifeStance Health (LFST) delivered earnings and revenue surprises of 0% and 6.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Oak Street Health, Inc. (OSH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of 9.68% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for January 12th

by Zacks Equity Research

APP, ACIW and ABM have been added to the Zacks Rank #5 (Strong Sell) List on January 12, 2023.

New Strong Sell Stocks for January 9th

by Zacks Equity Research

ADTN, AVAH and DBI have been added to the Zacks Rank #5 (Strong Sell) List on January 9, 2023.

New Strong Sell Stocks for January 4th

by Zacks Equity Research

AVAH, CBRL and ILMN have been added to the Zacks Rank #5 (Strong Sell) List on January 4, 2023.

Aveanna Healthcare (AVAH) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Aveanna (AVAH) delivered earnings and revenue surprises of -175% and 1.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?